NS1209 and Lidocaine in Patients With Peripheral Neuropathic Pain
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
Purpose: To evaluate the efficacy, tolerability and safety of NS1209 compared to lidocaine
and placebo in patients with peripheral chronic neuropathic pain.